Physician profile
Tariq Awan
NPI 1467403675
$113,478.97
in general payments reported to CMS, 2019-2025
14 companies · $45K in 2025
The $45K reported for 2025 was more than what 99% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $9,858 · 2021: $1,840 · 2022: $184 · 2023: $16K · 2024: $20K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $56K · Travel and Lodging: $12K · Honoraria: $10K · Food and Beverage: $2,347 · Education: $27.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $56,325.00 |
| Travel and Lodging | $11,547.38 |
| Honoraria | $10,260.00 |
| Food and Beverage | $2,347.47 |
| Education | $27.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $94,851.85 | 2019-2025 | Arthrex |
| Pacira Pharmaceuticals Incorporated | $15,352.15 | 2022-2025 | Iovera, Zilretta, Exparel |
| Curonix LLC | $1,247.92 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pinnacle, INC | $651.15 | 2019-2024 | |
| Fujifilm Sonosite, INC. | $600.00 | 2019-2020 | |
| Tenex Health INC. | $500.00 | 2019 | |
| Davol INC. | $67.73 | 2023 | |
| Trice Medical, INC. | $67.00 | 2022 | |
| Antares Pharma, INC. | $41.65 | 2024 | Xyosted |
| Ferring Pharmaceuticals INC. | $33.15 | 2024-2025 | Euflexxa |
| Bioventus LLC | $22.61 | 2024 | Durolane |
| Spr Therapeutics, INC | $22.15 | 2024 | Sprint Pns System |
| Viiv Healthcare Company | $21.61 | 2024 | Apretude, Cabenuva |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tariq Awan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.